Takayuki Nakano

Takayuki Nakano is an accomplished professional in the field of regenerative medicine and medical devices, currently serving as Director and Audit & Supervisory Committee Member at RaQualia Pharma Inc. since March 2025. Nakano holds multiple significant roles at Teijin Limited, including Mission Executive and General Manager of the Regenerative Medicine & Implantable Medical Device Division, along with board memberships in various Teijin subsidiaries. With a strong background in business planning and operations from over two decades at Takeda, Nakano has held several leadership positions, particularly within the Global Vaccine Business Unit. Educational qualifications include a Ph.D. in Medical Science from The University of Osaka, an MBA from Kenichi Ohmae Graduate School of Business, and a Master's and Bachelor's in Pharmaceutical Sciences from Tokyo University of Science.